Given recent successes with Presagen's image-based medical diagnostics platform, Presagen now sets its focus solely on medical diagnostics. Presagen's cloud AI platform is designed to rapidly develop globally scalable image-based medical diagnostics products. Presagen already has its first product in the fertility sector called Life Whisperer which uses AI to better select healthy embryos for IVF, and ultimately improve outcomes for couples wanting to have children.
Healthcare provision is unsustainable and artificial intelligence (AI) represents a $Billion opportunity in the sector. Globally, there is a growing number of AI companies in healthcare and a steep increase in investment in the MedTech sector more broadly. Despite this, the industry is still in its infancy with only a few medical AI applications that have been successfully commercialized.
Presagen's CEO Dr Michelle Perugini said "Presagen's vision is to become world-leaders in image-based medical diagnostics. Life Whisperer is soon to be launched into market, and we are exploring other broader opportunities in medical diagnostics in the U.S. and China."